Literature DB >> 1315087

Measurement of isotype-specific antibody responses to Aujeszky's disease virus in sera and mucosal secretions of pigs.

T G Kimman1, R A Brouwers, F J Daus, J T van Oirschot, D van Zaane.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) for the detection of porcine IgM, IgA, IgG1 and IgG2 antibodies directed against Aujeszky's disease virus (ADV) are described. ADV-specific IgA and IgM were detected in an antibody capture assay, and ADV-specific IgG1 and IgG2 were detected in an indirect double antibody sandwich assay. A selected set of samples was tested in the four ELISAs and in a 24 h virus neutralization assay. Comparison of the results showed that the ELISAs were isotype-specific, sensitive, and reproducible. Samples with ADV antibody of one isotype showed that ADV-specific IgG1, IgG2 and IgM were able to neutralize the virus in vitro. In vitro neutralization of virus can be enhanced by complement. ADV-specific IgA neutralized virus only weakly. ADV-infected cells activated complement in the absence of antibody. Specific IgG2 and IgM enhanced complement activation. Analysis of the time course of antibody responses after infection or vaccination revealed that the isotype-specific ELISAs are suitable to study the humoral antibody response of pigs to the virus in mucosal secretions. Wild-type virus (strain NIA-3) and an attenuated vaccine strain (Bartha) administered intranasally induced mucosal IgM and IgA responses to the virus. In contrast, a killed vaccine (Nobivac) administered intramuscularly induced only weak mucosal IgM responses. The attenuated vaccine strain primed for a mucosal IgA memory response evoked upon challenge infection with wild-type virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315087     DOI: 10.1016/0165-2427(92)90089-9

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.

Authors:  Hyun A Yoon; Seong Kug Eo
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

2.  Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier' and "non-carrier' cattle.

Authors:  J S Salt; G Mulcahy; R P Kitching
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

3.  Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine.

Authors:  B T Ober; A Summerfield; C Mattlinger; K H Wiesmüller; G Jung; E Pfaff; A Saalmüller; H J Rziha
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.

Authors:  Eugene M A van Rooij; Harrie L Glansbeek; Luuk A T Hilgers; Eddie G te Lintelo; Yolanda E de Visser; Wim J A Boersma; Bart L Haagmans; Andre T J Bianchi
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus.

Authors:  T G Kimman
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.

Authors:  Amanda E Calvert; Karen L Boroughs; Janeen Laven; Janae L Stovall; Betty E Luy; Olga I Kosoy; Claire Y-H Huang
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

7.  Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence.

Authors:  Eefke Weesendorp; Sophie Morgan; Norbert Stockhofe-Zurwieden; Ditta J Popma-De Graaf; Simon P Graham; Johanna M J Rebel
Journal:  Vet Microbiol       Date:  2012-09-19       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.